Moretti, A.; Paoletta, M.; Liguori, S.; Ilardi, W.; Snichelotto, F.; Toro, G.; Gimigliano, F.; Iolascon, G.
The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis. Int. J. Mol. Sci. 2021, 22, 2693.
https://doi.org/10.3390/ijms22052693
AMA Style
Moretti A, Paoletta M, Liguori S, Ilardi W, Snichelotto F, Toro G, Gimigliano F, Iolascon G.
The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis. International Journal of Molecular Sciences. 2021; 22(5):2693.
https://doi.org/10.3390/ijms22052693
Chicago/Turabian Style
Moretti, Antimo, Marco Paoletta, Sara Liguori, Walter Ilardi, Francesco Snichelotto, Giuseppe Toro, Francesca Gimigliano, and Giovanni Iolascon.
2021. "The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis" International Journal of Molecular Sciences 22, no. 5: 2693.
https://doi.org/10.3390/ijms22052693
APA Style
Moretti, A., Paoletta, M., Liguori, S., Ilardi, W., Snichelotto, F., Toro, G., Gimigliano, F., & Iolascon, G.
(2021). The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis. International Journal of Molecular Sciences, 22(5), 2693.
https://doi.org/10.3390/ijms22052693